These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21470025)

  • 1. Preexposure chemoprophylaxis for HIV prevention.
    Sellier PO; Lafuente-Lafuente C; Roques P
    N Engl J Med; 2011 Apr; 364(14):1373; author reply 1374-5. PubMed ID: 21470025
    [No Abstract]   [Full Text] [Related]  

  • 2. Preexposure chemoprophylaxis for HIV prevention.
    Underhill K
    N Engl J Med; 2011 Apr; 364(14):1374; author reply 1374-5. PubMed ID: 21470023
    [No Abstract]   [Full Text] [Related]  

  • 3. Preexposure chemoprophylaxis for HIV prevention.
    Pittrof R; Sauer U; French P
    N Engl J Med; 2011 Apr; 364(14):1374; author reply 1374-5. PubMed ID: 21470022
    [No Abstract]   [Full Text] [Related]  

  • 4. Preexposure chemoprophylaxis for HIV prevention.
    Lee DH; Vielemeyer O
    N Engl J Med; 2011 Apr; 364(14):1372-3; author reply 1374-5. PubMed ID: 21470026
    [No Abstract]   [Full Text] [Related]  

  • 5. Preexposure chemoprophylaxis for HIV prevention.
    Pimpinella G; Malgarini RB
    N Engl J Med; 2011 Apr; 364(14):1373; author reply 1374-5. PubMed ID: 21470024
    [No Abstract]   [Full Text] [Related]  

  • 6. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
    Grant RM; Lama JR; Anderson PL; McMahan V; Liu AY; Vargas L; Goicochea P; Casapía M; Guanira-Carranza JV; Ramirez-Cardich ME; Montoya-Herrera O; Fernández T; Veloso VG; Buchbinder SP; Chariyalertsak S; Schechter M; Bekker LG; Mayer KH; Kallás EG; Amico KR; Mulligan K; Bushman LR; Hance RJ; Ganoza C; Defechereux P; Postle B; Wang F; McConnell JJ; Zheng JH; Lee J; Rooney JF; Jaffe HS; Martinez AI; Burns DN; Glidden DV;
    N Engl J Med; 2010 Dec; 363(27):2587-99. PubMed ID: 21091279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating HIV prevention into practice.
    Mathers BM; Cooper DA
    JAMA; 2014 Jul 23-30; 312(4):349-50. PubMed ID: 25038352
    [No Abstract]   [Full Text] [Related]  

  • 8. When is good good enough for HIV-1 prophylaxis?
    Buchbinder S
    Lancet Infect Dis; 2014 Nov; 14(11):1024-1025. PubMed ID: 25300861
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic preexposure prophylaxis for HIV: translating clinical data to clinical practice.
    Li J; Dufrene SL; Okulicz JF
    Ann Pharmacother; 2014 Apr; 48(4):507-18. PubMed ID: 24473492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jun; 62(23):463-5. PubMed ID: 23760186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ART of preventing HIV.
    Nat Med; 2011 Jan; 17(1):46-7. PubMed ID: 21217682
    [No Abstract]   [Full Text] [Related]  

  • 12. Re.: Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
    Berger RE
    J Urol; 2011 May; 185(5):1729-30. PubMed ID: 22088703
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA treads carefully with PrEP.
    Holmes D
    Lancet Infect Dis; 2012 Jul; 12(7):515-6. PubMed ID: 22930826
    [No Abstract]   [Full Text] [Related]  

  • 14. Preexposure prophylaxis for HIV--where do we go from here?
    Cohen MS; Baden LR
    N Engl J Med; 2012 Aug; 367(5):459-61. PubMed ID: 22784041
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.
    Myers GM; Mayer KH
    AIDS Patient Care STDS; 2011 Feb; 25(2):63-71. PubMed ID: 21284497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco.
    Liu A; Cohen S; Follansbee S; Cohan D; Weber S; Sachdev D; Buchbinder S
    PLoS Med; 2014 Mar; 11(3):e1001613. PubMed ID: 24595035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The British HIV Association/British Association for Sexual Health and HIV Position Statement on pre-exposure prophylaxis in the UK.
    McCormack S; Fidler S; Fisher M; ;
    Int J STD AIDS; 2012 Jan; 23(1):1-4. PubMed ID: 22362679
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent HIV-1 infection: to treat or not to treat, that is the question.
    Tossonian H; Conway B
    J Infect Dis; 2012 Jan; 205(1):10-2. PubMed ID: 22180623
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid improvement in fasting lipids and hepatic toxicity after switching from didanosine/lamivudine to tenofovir/emtricitabine in patients with toxicity attributable to didanosine.
    Palacios R; Rivero A; Santos I; Ríos MJ; Castaño M; del Arco A; Santos González J;
    HIV Clin Trials; 2010; 11(2):118-20. PubMed ID: 20542848
    [No Abstract]   [Full Text] [Related]  

  • 20. Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants.
    Fuchs JD; Sobieszczyk ME; Madenwald T; Grove D; Karuna ST; Andrasik M; Sherwat A; Broder G; Mayer K; Koblin B; Hammer S;
    J Acquir Immune Defic Syndr; 2013 Jul; 63(3):259-62. PubMed ID: 23614998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.